Return
A Scoping Review of Australian Hospitals' Policies on the Deactivation of Implantable Cardioverter Defibrillators
DOI:10.1016/j.hlc.2025.12.019.png)
Abstract
En 中文
Aim More older adults are living with an implantable cardioverter defibrillator (ICD). Deactivation rates for those approaching end-of-life are low, risking undue distress and an undignified death. This scoping review aimed to determine the availability and content of hospital guidance documents regarding ICD deactivation towards end-of-life. Method Guidelines' databases from two Australian states (Victoria and South Australia) were systematically searched between September 2022 to February 2023, to identify all documents that specified guidance for ICD deactivation at end-of-life. Relevant documents were analysed using a pre-specified data extraction tool. Results Following screening of 59,662 documents from 94 health services providing acute, aged or palliative care, 11 were included. Most were from public (10, 91%), metropolitan (eight, 73%) health services. Guidance on timing of ICD deactivation discussions was limited; only two (18%) documents advised discussion at time of insertion, one (9%) at generator change and six (55%) during advance care planning discussions. Recommended criteria for ICD deactivation varied: people with a terminal illness (two, 18%), with an active do not resuscitate order (five, 45%), receiving end-of-life care (11, 100%), or at the person's request (seven, 64%). Nine (82%) recommended consent dialogue that deactivation does not cause/hasten death (eight, 73%) or deactivate pacing (eight, 73%), aims to promote a peaceful death (eight, 73%) and that reactivation is possible (eight, 73%). Conclusions There is a paucity of local health service guidance to support clinicians navigating ICD deactivation at end-of-life.
Keywords:
Implantable cardioverter defibrillator
Deactivation
End-of-life
Cardiovascular implantable electronic device
Palliative care
Journal
H
IF:
2.2
Papers:
172
Citations:
4.6K

